JPS6328393A - Novel plasmid - Google Patents
Novel plasmidInfo
- Publication number
- JPS6328393A JPS6328393A JP61169859A JP16985986A JPS6328393A JP S6328393 A JPS6328393 A JP S6328393A JP 61169859 A JP61169859 A JP 61169859A JP 16985986 A JP16985986 A JP 16985986A JP S6328393 A JPS6328393 A JP S6328393A
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- megadaltons
- gene
- promoter
- pmtp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 110
- 239000012634 fragment Substances 0.000 claims abstract description 88
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 17
- 241000588724 Escherichia coli Species 0.000 claims abstract description 16
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 claims abstract description 15
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 claims abstract description 15
- 230000010076 replication Effects 0.000 claims abstract description 7
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 20
- 108700005075 Regulator Genes Proteins 0.000 claims description 11
- 238000003776 cleavage reaction Methods 0.000 claims description 11
- 230000007017 scission Effects 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 10
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 10
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 10
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 230000001276 controlling effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 229940107700 pyruvic acid Drugs 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 239000013611 chromosomal DNA Substances 0.000 claims description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- 241001646716 Escherichia coli K-12 Species 0.000 claims 1
- 238000005520 cutting process Methods 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 238000005192 partition Methods 0.000 abstract 2
- 238000006257 total synthesis reaction Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 23
- 239000002609 medium Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229960004799 tryptophan Drugs 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000006152 selective media Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- 241000555745 Sciuridae Species 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 101150099895 tnaA gene Proteins 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- -1 5-7 mifindole Chemical compound 0.000 description 2
- HUNCSWANZMJLPM-UHFFFAOYSA-N 5-methyltryptophan Chemical compound CC1=CC=C2NC=C(CC(N)C(O)=O)C2=C1 HUNCSWANZMJLPM-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ZTTWHZHBPDYSQB-UHFFFAOYSA-N 2-azaniumyl-3-(1h-indol-3-yl)-2-methylpropanoate Chemical compound C1=CC=C2C(CC(N)(C)C(O)=O)=CNC2=C1 ZTTWHZHBPDYSQB-UHFFFAOYSA-N 0.000 description 1
- LMIQERWZRIFWNZ-UHFFFAOYSA-N 5-hydroxyindole Chemical compound OC1=CC=C2NC=CC2=C1 LMIQERWZRIFWNZ-UHFFFAOYSA-N 0.000 description 1
- YPKBCLZFIYBSHK-UHFFFAOYSA-N 5-methylindole Chemical compound CC1=CC=C2NC=CC2=C1 YPKBCLZFIYBSHK-UHFFFAOYSA-N 0.000 description 1
- ONYNOPPOVKYGRS-UHFFFAOYSA-N 6-methylindole Natural products CC1=CC=C2C=CNC2=C1 ONYNOPPOVKYGRS-UHFFFAOYSA-N 0.000 description 1
- 241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000617478 Escherichia coli (strain K12) PTS system fructose-like EIIA component Proteins 0.000 description 1
- 108010076282 Factor IX Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- IDIDJDIHTAOVLG-UHFFFAOYSA-N S-methyl-L-cysteine Natural products CSCC(N)C(O)=O IDIDJDIHTAOVLG-UHFFFAOYSA-N 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101100046503 Symbiobacterium thermophilum (strain T / IAM 14863) tnaA1 gene Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- UQVDQSWZQXDUJB-UHFFFAOYSA-N hydron;7h-purin-6-amine;chloride Chemical compound Cl.NC1=NC=NC2=C1NC=N2 UQVDQSWZQXDUJB-UHFFFAOYSA-N 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012134 supernatant fraction Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はトリプトアナーゼの生合成を司る遺伝子を含む
DNA断片を含有する新規なプラスミドに関し、更に詳
しくは、コピー数が多く、宿主内での安定保持性に優れ
ており、細胞増殖に際して脱落することなく、親細胞か
ら娘細胞に確実1こ受は継がれる、トリプトアナーゼの
生合成を77]る遺伝子tna Aとこの遺伝子を発現
させうるプロモーターとこのプロモーターを制御する調
節遺伝子をもつDNA断片とを含むD N A断片を含
有するプラスミドに関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel plasmid containing a DNA fragment containing a gene responsible for the biosynthesis of tryptoanase, and more specifically, a novel plasmid that has a large number of copies and is highly stable in the host; The gene tnaA, which performs the biosynthesis of tryptoanase, which is not shed during cell proliferation and is surely inherited from the parent cell to the daughter cell, the promoter that can express this gene, and the regulatory gene that controls this promoter. The present invention relates to a plasmid containing a DNA fragment containing a DNA fragment having
一般に造成プラスミドの宿主内での安定性に関して、従
来より、培養時に宿主からのプラスミドの脱落や挿入遺
伝子の欠落等種々の遺伝子的不安定性が報告されでおり
、その対応策が検討されている。In general, with regard to the stability of constructed plasmids within the host, various genetic instabilities have been reported, such as dropout of the plasmid from the host during culture and loss of inserted genes, and countermeasures are being considered.
例えば、エシェリヒア属のストレプトマイシンに依存し
ないという性質を司る染色体遺伝子DNA断片が組み込
まれたプラスミドを、エシェリヒア属のストレプトマイ
シン依存性変異株に含有せしめて、プラスミドを含有す
る微生物の性質を安定化する方法が提案されている(特
開昭55−156591号公報)。For example, there is a method of stabilizing the properties of a microorganism containing the plasmid by incorporating a plasmid into a streptomycin-dependent mutant strain of Escherichia that controls the property of being independent of streptomycin. It has been proposed (Japanese Unexamined Patent Publication No. 156591/1983).
しかしながら、かかる方法はに¥、済的に問題があるの
みならず、0的のプラスミドに複雑な機能を組み込む必
要がおるため、宿主の分裂増殖時にプラスミドが安定1
こ娘細胞に分配され難いことが予想され、工業的1こ応
用するにはかなりの問題がある。However, this method not only has economical problems, but also requires the incorporation of complex functions into the target plasmid, which makes it difficult for the plasmid to remain stable during host division and multiplication.
It is expected that it will be difficult to distribute to daughter cells, and there will be considerable problems in its industrial application.
そこで、本発明者らは、トリプトアナーゼの生合成をi
rJる遺伝子の宿主内安定化を図るべく、まず、親細胞
から娘細胞へと継代的に安定に分配することを可能にす
る機能をもつプラスミドについて鋭、ま研究を行ない、
F因子プラスミドの増殖制御分配系をrfJる遺伝子を
含むDNAD片がプラスミドの安定化に大きく寄与する
能力があること、そしてさらに、エシェリヒア・コリの
ColEl系プラスミドが通常細胞染色体当り数十個の
コピー数を有することに着目し、今回、Co1El系プ
ラスミドの自律増殖能を司る遺伝子を含むDNA1¥I
i片と、F因子プラスミドの増殖制御分配系を司る遺伝
子を含むDNA断片とを、上記のトリプトアナーゼの生
合成を司る遺伝子を含むD N A断片とを組合せるこ
とにより、コピー数が多くしがも継代的に安定に分配可
能なプラスミドを創製することに成功し、本発明を完成
するに至った。Therefore, the present inventors investigated the biosynthesis of tryptoanase i.
In order to stabilize the rJ gene in the host, we first conducted intensive research on plasmids that have the function of allowing stable distribution from parent cells to daughter cells over successive generations.
The DNA fragment containing the rfJ gene, which controls the F-factor plasmid's growth control distribution system, has the ability to significantly contribute to plasmid stabilization, and furthermore, the ColEl-based plasmid of Escherichia coli normally has several dozen copies per cell chromosome. Focusing on the fact that Co1El-based plasmids have a large number of
By combining the DNA fragment containing the gene governing the growth control distribution system of the F factor plasmid with the DNA fragment containing the gene governing the biosynthesis of tryptoanase, the number of copies can be increased. They also succeeded in creating a plasmid that can be stably distributed through generations, leading to the completion of the present invention.
しかして、本発明によれば、
(a)トリプトフアナーゼオペロン中の少なくともプロ
モーター及びこのプロモーターを制御する調節遺伝子並
びにトリプトアナーゼ構造遺伝子を含むD N A断片
と、(b) ColEl系プラスミドの自律増殖能を
司るD N A断片と、
(c) Fプラスミド由来の増殖制御分配系を司る遺
伝子を含むDNA断片
とから成ることを特徴とする新規なプラスミドが提供さ
れる。Therefore, according to the present invention, (a) a DNA fragment containing at least a promoter in the tryptophanase operon, a regulatory gene that controls this promoter, and a tryptophanase structural gene, and (b) the ability to autonomously reproduce a ColEl-based plasmid. and (c) a DNA fragment containing a gene that controls the proliferation control distribution system derived from the F plasmid.
本発明のプラスミドを構成する「トリプトフアナーゼオ
ペロン中の少なくともプロモーター及びこのプロモータ
ーを制御する調節遺伝子並びにトリプトアナーゼNII
造遺伝子を含むDNA断片」(以下「T断片」と略称す
ることがある)は、トリプトファンをインドールとピル
ビン酸とアンモニアに分解する役割をもつ#素、すなわ
ちトリプトアナーゼの生合成を司る遺伝子を含むDNA
断片を意味し、本発明で用いるT断片には、殊に、トリ
プトフアナーゼオペロン中のトリプトアナーゼの生合成
を司る遺伝子であるLnaAを発現させうるプロモータ
ー機能をもつDNA断片(以下[トリプト7アナーゼプ
ロモーター]というとがある)及びさらに必要に応じて
このプロモーター機能を制御しうる調節遺伝子をもつD
NA断片を結合したDNA断片が包含される。かかるT
断片としては実用的には大腸菌白米のものが好適に使用
される。At least a promoter in the tryptophanase operon, a regulatory gene that controls this promoter, and tryptophanase NII, which constitute the plasmid of the present invention.
"DNA fragment containing a synthetic gene" (hereinafter sometimes abbreviated as "T fragment") is a DNA fragment containing a gene that controls the biosynthesis of tryptoanase, a #element that plays the role of decomposing tryptophan into indole, pyruvate, and ammonia.
In particular, the T fragment used in the present invention includes a DNA fragment (hereinafter referred to as [tryptophanase promoter]) and, if necessary, a regulatory gene that can control this promoter function.
Includes DNA fragments joined with NA fragments. It takes T
Practically speaking, E. coli white rice fragments are preferably used as the fragments.
このT断片の供給源としては特に制限はなり・が、エシ
ェリヒア・コリATCC23282、エシエリヒア・コ
リATCC23437、エシェリヒア・コリATCC2
3461等が有利に使用される。There are no particular restrictions on the source of this T fragment, but Escherichia coli ATCC23282, Escherichia coli ATCC23437, Escherichia coli ATCC2
3461 etc. are advantageously used.
これら供給源微生物から本発明の目的に適うtna A
断片と)リプト7アナーゼプロモーター及びこのプロモ
ーターを制御する調節遺伝子とが結合したDNA断片を
調製するための詳細な方法は後記実施例1の(A)に示
すが、基本繰作としては、染色体遺伝子中にトリプトフ
アナーゼオペロンをもつ大腸菌の染色体遺伝子を抽出し
、制限酵素Bawl−11、II 1ndIIIを用い
てトリプトフアナーゼオペロンDNA断片を切り出すと
tna A及びトリプト7アナーゼプロモーター及びこ
のプロモーターを制御する調節遺伝子を含むDNA断片
が得られる。From these source microorganisms, tna A suitable for the purpose of the present invention
A detailed method for preparing a DNA fragment in which the lypto-7anase promoter and the regulatory gene that controls this promoter are combined is shown in (A) of Example 1 below, but the basic procedure is to Extracting the chromosomal gene of E. coli that has a tryptophanase operon in the gene, and cutting out the tryptophanase operon DNA fragment using restriction enzymes Bawl-11, II 1ndIII, controls the tnaA and tryptophanase promoters and this promoter. A DNA fragment containing the regulatory gene is obtained.
本発明はfij述しtこように、上記のT断片を、F因
子プラスミド由来のプラスミドの増殖制御分配系を司る
遺伝子を含むDNA断片と組合わせる点に1つの特徴を
有する。F因子プラスミドは例えば[蛋白質 4f酸
1sLXJJ27巻第1t[1982)の98頁の図1
の遺伝子地図及びEcoRIによる物理的地図に示され
る如き構造をもつ、分子量が94.5kb(62X10
’グルトン)の既知のプラスミドであり、大腸菌などの
腸内細菌中に通常細胞染色体当り1〜2個のコピー数で
存在し、このプラスミドは細胞分裂後にそれぞれの娘細
胞中に正確に伝達されるような機構を備えている(この
ように、コピー数を低いレベルに保ちつつ、正確に宿主
の増殖とベースを合わせて増やす仕組みを5Lrin8
enLな増殖の制御と呼んでいる)、F因子プラスミド
におけるこのような5triBenLな増殖の制御(5
!1能が、wini−Fと呼ばれる分子量が9.2kb
の自律増殖できる断片に担われていることも既に究明さ
れており[”Mo1ecular&General
geneties”196.185−193(1984
)]、このm1ni−FがF因子プラスミドより制限酵
素EcoRIにより切り出し可能であることも知られて
いる。As described above, one feature of the present invention is that the above-mentioned T fragment is combined with a DNA fragment containing a gene that controls the growth control distribution system of a plasmid derived from the F factor plasmid. The F factor plasmid is, for example, [Protein 4f acid
Figure 1 on page 98 of 1sLXJJ Vol. 27, No. 1t [1982]
The molecular weight is 94.5 kb (62 x 10
Gluton), which is present in enterobacteria such as Escherichia coli, usually at a number of 1 to 2 copies per cell chromosome, and this plasmid is accurately transmitted into each daughter cell after cell division. (In this way, 5Lrin8 has a mechanism to keep the copy number at a low level and increase the base accurately with the proliferation of the host.
enL growth control), such 5triBenL growth control in the F factor plasmid (5triBenL growth control)
! 1 has a molecular weight of 9.2 kb called wini-F.
It has already been found that the fragments that can autonomously reproduce ["Mo1cular &General"]
genes”196.185-193 (1984
)], it is also known that this m1ni-F can be excised from the F factor plasmid using the restriction enzyme EcoRI.
本発明はこのm1ni−Fに担われている増殖制御分配
系を利用するものであり、しかして「F因子プラスミド
由来の増殖制御分配系を司る遺伝子を含むDNA断片」
(以下「F断片」と略称することがある)は、上述した
ようなF因子プラスミドを娘細胞に正確に伝達する機構
を備えた遺伝子画分を意味し、その上うなF断片の代表
例としては約9゜2kbの分子量を有するm1ni−F
断片が挙げられる。The present invention utilizes the growth control distribution system carried by this m1ni-F, and thus "DNA fragment containing the gene controlling the growth control distribution system derived from the F factor plasmid"
(hereinafter sometimes abbreviated as "F fragment") means a gene fraction equipped with a mechanism for accurately transmitting the F factor plasmid to daughter cells, as described above. is m1ni-F with a molecular weight of approximately 9°2 kb.
Fragments are mentioned.
さらに、本発明において一ヒ記T断片及びF断片と組合
わせて使用される「colEi系プラスミド由来の自律
増殖を司る遺伝子を含むDNA断片」(以下「S断片」
と略称することがある)は、コピー数が1細胞染色体当
り20〜30個であるCo1El系プラスミドの自律増
殖を司る遺伝子を含むDNA断片を意味し、その上うな
S断片の代表例としては約4 、3 kbの長さを有す
るプラスミドpBR322由米のS断片が挙げられ、そ
の他にプラスミドル81325等由来のS断片がある。Furthermore, in the present invention, a "DNA fragment containing a gene that controls autonomous replication derived from a colEi-based plasmid" (hereinafter referred to as "S fragment") is used in combination with the T fragment and F fragment described above.
(sometimes abbreviated as ) refers to a DNA fragment containing a gene that controls the autonomous replication of Co1El-based plasmids with a copy number of 20 to 30 copies per cell chromosome, and a typical example of an S fragment is approximately Examples include the S fragment of plasmid pBR322 Yume, which has a length of 4.3 kb, and S fragments derived from plasmid pBR322 and the like.
本発明により提供されるプラスミドは、以上に述べたT
断片、F断片及びS断片の3つの必須のDNA断片を有
する限り、池の遺伝情報を担つDNA断片、例えば抗生
物質耐性マーカーであるアンビシリン耐性遺伝子を含む
DNA断片、カナマイシン耐性遺伝子を含むDNA断片
等をさらに含みうるが、典型的な具体例は、T断片、F
断片及びS断片の3つのDNAIEII片から実質的に
なり、分子量が約10.7メガダルトン(約16.4k
b)のプラスミドで、本発明者らが[プラスミドpM
T P −11及び「プラスミドpMTP−IRJと命
名した2種のプラスミドである。プラスミドpMTP−
IR。The plasmid provided by the present invention is the T
A DNA fragment that carries the genetic information of Ike, as long as it has three essential DNA fragments: F fragment, F fragment, and S fragment, such as a DNA fragment containing the ambicillin resistance gene, which is an antibiotic resistance marker, and a DNA fragment containing the kanamycin resistance gene. Typical examples include T fragments, F fragments, etc.
It consists essentially of three DNAIEII fragments, the fragment and the S fragment, and has a molecular weight of approximately 10.7 megadaltons (approximately 16.4 k
In the plasmid b), the inventors [plasmid pM
The two plasmids were named plasmid pMTP-IRJ and plasmid pMTP-IRJ.
IR.
プラスミドpMTPiのmi旧−F断片部分が逆向きに
配位している以外はプラスミドpMTPiと同じ構造の
ものである6
なお、本明細書において、プラスミドの分子量はアガロ
ースデル電気泳動法により測定した値である。Plasmid pMTPi has the same structure as plasmid pMTPi except that the mi old-F fragment part is arranged in the opposite direction6. In addition, in this specification, the molecular weight of plasmid is the value measured by agarose del electrophoresis. It is.
以下、このプラスミドpMTP−1及びpM T P
−IRについてさらに詳細に説明する。Hereinafter, this plasmid pMTP-1 and pMTP
- IR will be explained in more detail.
プラスミドpMTP−1及びpMTP−IHの下記の制
限H索の感受性(認識部位の数)及び該制限酵素による
分解断片の氏さくkb)は下記の表に示すとおりである
。The susceptibilities (number of recognition sites) of plasmids pMTP-1 and pMTP-IH to the following restriction sequences (number of recognition sites) and the length (kb) of fragments degraded by the restriction enzymes are shown in the table below.
プラスLLpMTP−1
CcoRI 2 9.2.7.2B
an)II 3
9.9、 4.1、 2.4Hind[I[2
8,4,8,0
Aval 2 3.9.12.
5PstI 6 4,9.4.0.3.
8.1.8.1.5.0.4SalI 2
12.7.3.7EcoRI 2
9.2.7.2nig)(I
3 10.7、3.3、2.4Hind
lII 2
0.8、 15.6AvaI 2
3.9.12.5Pstl
6 4.9.4.9.2.9.1.8.1.5
.0.4SalI 2 12,6
.3.8また、プラスミドpMTP−1及びpMTP−
IRの制限酵素切断地図を添付の第1図及!J第2図に
示す。Plus LLpMTP-1 CcoRI 2 9.2.7.2B
an) II 3
9.9, 4.1, 2.4Hind[I[2
8,4,8,0 Aval 2 3.9.12.
5PstI 6 4,9.4.0.3.
8.1.8.1.5.0.4 SalI 2
12.7.3.7EcoRI 2
9.2.7.2nig) (I
3 10.7, 3.3, 2.4Hind
II 2
0.8, 15.6 AvaI 2
3.9.12.5Pstl
6 4.9.4.9.2.9.1.8.1.5
.. 0.4SalI2 12,6
.. 3.8 Also, plasmids pMTP-1 and pMTP-
The IR restriction enzyme cleavage map is attached in Figure 1! J is shown in Figure 2.
以上に述べた如き特性をもつ本発明のプラスミドpMT
P−1及びpMTP−IRは、例えば次のようにして製
造することができる。Plasmid pMT of the present invention having the characteristics as described above
P-1 and pMTP-IR can be produced, for example, as follows.
まず、lla A断片にトリプト7アナーゼプロモータ
ー及びこのプロモーターを制御する調節遺伝子を結合し
たDNAI!Ii片(T断片)の調製は、例えば、染色
体遺伝子中にトリプトフアナーゼオペロンをもつ大腸菌
、例えば、Escherichia eoliK−1
2(IFO3301、ATCC10798、ATCCe
23562)などから染色体DNAを抽出し、それから
常法[E、F、Fr1Lseh、 Sambr。First, DNAI!A fragment in which a trypto-7anase promoter and a regulatory gene that controls this promoter are linked to the lla A fragment! The Ii fragment (T fragment) can be prepared using, for example, Escherichia coli that has a tryptophanase operon in its chromosomal gene, such as Escherichia eoliK-1.
2 (IFO3301, ATCC10798, ATCCe
23562), etc., and then extracted using a conventional method [E, F, Fr1Lseh, Sambr.
ok、Mo1ecular atoning″(19
82)p、164〜165、Cold S prin
gHarbor L aborat。OK, Mo1ecular atoning'' (19
82) p, 164-165, Cold S print
gHarbor L aborat.
rye照1に従って、制限酵素BaIIIHI及1トr
indllrを用いてトリプトフアナーゼオペロンDN
A断片を切り出すと、約3.2kbのトリプト7アナー
ゼブロモーター及びこのプロモーターを制御する調遺伝
子並びにtnaAを含むT断片がイ;シられる。Restriction enzymes BaIIIHI and 1TR according to Rye
Tryptophanase operon DN using indllr
When the A fragment is excised, a T fragment containing the approximately 3.2 kb trypto-7 anase promoter, the regulatory gene that controls this promoter, and tnaA is excised.
一方、m1ni−F断片の調節は、例えば、F因9プラ
スミドを保有する微生物、例えば、大腸菌(Ecoli
)K −12株(ATCCI 5153、ATCCe2
3589、ATCCc23590)Wからそれ自体公知
の方法で、例えばP、Guerry+ DL。On the other hand, the regulation of the m1ni-F fragment can be carried out, for example, by microorganisms carrying the F factor 9 plasmid, such as Escherichia coli (Ecoli).
) K-12 strain (ATCCI 5153, ATCCe2
3589, ATCC c23590) W in a manner known per se, for example P, Guerry+ DL.
1−e Blanc、 S、Falkow;J、Ba
cLo、11 G、。1-e Blanc, S, Falkow; J, Ba
cLo, 11 G,.
1064(1973)等の文献に記載の方法でF因子プ
ラスミドを取り出し、それから制限酵素Ec。1064 (1973), etc., to extract the F factor plasmid, and then use the restriction enzyme Ec.
R1を用いて分子量が約9.2kbの信;旧−F断片を
切り出すことにより調製することができる。It can be prepared by cutting out the F-F fragment with a molecular weight of about 9.2 kb using R1.
他方、Co1E1プラスミドの自律増殖を司る遺伝子を
含むDNA断片の供給源としては、Co1E1プラスミ
ドとして代表的なプラスミドpBR322を使用するの
が便利である。On the other hand, it is convenient to use plasmid pBR322, which is a typical Co1E1 plasmid, as a source of a DNA fragment containing a gene that controls autonomous replication of the Co1E1 plasmid.
上記の如くして調製されたT断片を制限酵素BamHI
及[7Hind[[で処理したプラスミドpB R32
2と一緒にし、T4’DNAす〃−ゼを作用させて、プ
ラスミドpBR322に上記T断片が組み込まれたプラ
スミドを作成する。次いで、このプラスミドをEcoR
Iで開!iさせ、上記のようにして調製されたm1ni
−F断片と一緒にし、T4DNAす〃−ゼを作用させて
結合させることにより、目的とするプラスミドpMTP
・1及びpM T P −IRを得ることができる。The T fragment prepared as above was treated with the restriction enzyme BamHI.
Plasmid pB R32 treated with [7Hind[[
2 and treated with T4' DNAase to create a plasmid in which the above T fragment is integrated into plasmid pBR322. This plasmid was then transformed into EcoR
Open with I! m1ni prepared as above.
The target plasmid pMTP is combined with the -F fragment and ligated with T4 DNAase.
-1 and pM T P -IR can be obtained.
なお、プラスミドpM T P −1およびpMTP−
IRの呉体的調製法については後記実施例1でさらに詳
細に説明する。In addition, plasmids pMTP-1 and pMTP-
The method for preparing IR will be described in more detail in Example 1 below.
このようにして調5!すれる本発明のプラスミドは、フ
ビー数、75C多く、宿主の細胞分裂に際して娘細胞に
受は継がれる際に脱落することが少なく安定であるとい
う優れた特性を有する。In this way, key 5! The plasmid of the present invention has excellent characteristics such as having a large number of fuvies (75C), being stable and less likely to be shed when passed on to daughter cells during cell division of the host.
従って、本発明のプラスミドはトリプトファンもしくは
トリプトファン透導体の製造において工業的に応用する
ことが大いに期待される。トリプトファンの製造に際し
ては、本発明のプラスミドで宿主が形質転換される。こ
の形質転換に利用できる宿主菌としては、大腸菌が好ま
しい。Therefore, it is highly anticipated that the plasmid of the present invention will be industrially applied in the production of tryptophan or tryptophan-permeable conductors. For the production of tryptophan, a host is transformed with the plasmid of the present invention. Escherichia coli is preferred as a host bacterium that can be used for this transformation.
また、これら宿主菌に対する本発明のプラスミドの導入
はそれ自体公知の方法、例えば、M 、 M ande
l、A、HiHa;J、Mol、 Biol、 53
.159(1970)等の文献に記載の方法で行うこと
ができる。In addition, the plasmid of the present invention can be introduced into these host bacteria using methods known per se, such as M, M ande.
l, A, HiHa; J, Mol, Biol, 53
.. 159 (1970) and the like.
このようにして形質転換された宿主菌はそれ自体公知の
方法で培養することにより、トリプトアナーゼを菌体内
に充分に生産蓄積させることができる。By culturing the host fungus transformed in this manner by a method known per se, tryptoanase can be sufficiently produced and accumulated within the microbial cell.
トリプトアナーゼは、Agricultural a
ndB iological Cbemistry
V of 36、N013、P2523〜2528(
1972)、特公告昭49−46917号公報などの文
献により知られているように、インドール、5ヒドロキ
シインドール、5−7ミフインドール、5−メチルイン
ドールなどのインドール類と、ピルビン酸、オキザロ酢
酸、リンゴ酸、7マール酸、グリオキシル酸、乳酸など
の有機酸の少なくとも1つと、アンモニウムイオンとか
ら;あるいは上記インドール類とシスティン、シスチン
、S−メチルシスティン、セリンなどのアミノ酸のうち
の少なくとも1つとから、L−)リブリフアンまたはL
−)すブト7アン誘導体を製造する際の酵素反応に利用
することができる。Tryptoanase is an agricultural
ndB iological Cbemistry
V of 36, N013, P2523-2528 (
1972) and Japanese Patent Publication No. 49-46917, indoles such as indole, 5-hydroxyindole, 5-7 mifindole, 5-methylindole, pyruvic acid, oxaloacetic acid, from at least one organic acid such as malic acid, hepatomaric acid, glyoxylic acid, lactic acid, and ammonium ion; or from the above indoles and at least one amino acid such as cysteine, cystine, S-methylcysteine, serine, etc. , L-) Librifan or L
-) It can be used in enzymatic reactions during the production of Sub7-an derivatives.
しかして、培養された菌体を該酵素反応に+11用する
場合、該菌体はそのままで使用することができるが、該
菌体を超音波処理等で破砕した破砕物、又はその破砕物
をさらに水等で抽出した抽出物、或いは該抽出物をさら
に硫安等で処理して酸素成分を沈澱させた粗N製物の形
で使用することらでき、さらに、該菌体又はそれら処理
物は必要により固体化して用いることもできる。When using the cultured bacterial cells for the enzymatic reaction, the bacterial cells can be used as they are, but they can be crushed by ultrasonication or the like, or Furthermore, it can be used in the form of an extract extracted with water or the like, or a crude N product obtained by further treating the extract with ammonium sulfate or the like to precipitate oxygen components, and furthermore, the bacterial cells or the treated product can be used in the form of a crude N product. It can also be used after being solidified if necessary.
該菌体又はその処理物の存在下でのインドールとピルビ
ン酸またはその塩とアンモニウムイオンとの反応は、通
常の酵素反応と同様に例えば0゜1 M ’) 7酸緩
衝1ffl(pH7,5−10,0)あるいは水(pi
(7,5〜10.0)等の溶媒中で、約20〜約50°
C1好ましくは約30〜約40°Cの温度で通常約10
〜約72時間で行なわれる。The reaction between indole, pyruvic acid or its salt, and ammonium ion in the presence of the microbial cells or their processed material is carried out in the same way as a normal enzyme reaction, for example, using 1 ffl of 0°1 M' heptacid buffer (pH 7,5- 10,0) or water (pi
(7,5-10.0), about 20 to about 50°
C1 preferably at a temperature of about 30 to about 40°C and usually about 10
It takes about 72 hours.
インドールとピルビン酸またはその塩とアンモニウムイ
オンの反応時の使用量、酵素反応に対し阻害がない程度
の濃度であれば特に制限はないが、一般にはそれぞれを
0.1−20%(wt/vol)の濃度範囲で使用する
のが適当である。まtこ、該菌体又はその処理物の使用
量もVflこ制限されるものではないが、一般に1〜1
0%(wt/vol)の濃度で使用することができる。There is no particular restriction on the amount of indole, pyruvate or its salt, and ammonium ion used in the reaction, as long as the concentration does not inhibit the enzymatic reaction, but generally each is used at 0.1-20% (wt/vol). ) is suitable for use within the concentration range. Although the amount of the bacterial cells or the processed product thereof is not limited, it is generally 1 to 1.
It can be used at a concentration of 0% (wt/vol).
なお、上記形質転換された菌の培養は、宿主菌の種類に
よって異なるが、一般には、通常用いられる合成或いは
天然培地を用いて行なうことができる。しかして炭素源
としては、グルツース□、グリセロール、7ラクトース
、シュクロース、糖蜜等の種々の炭化化物が使用できる
。まjこ、窒素源としては、トリプトン、酵母エキス、
コーン・スチープ・リカー、カゼイン加水分解物等の天
然6機窒素源が使用できる。天然有機窒素源の多くは窒
素源と共に炭素源にもなり得る。また、培地には、L−
)リプドアアン及び/又は5−メチルトリプトファン、
5−オキシトリプトファン等などのトリプトファン誘導
体を通常0.01%(四t/vol)以上、好ましくは
0.1%〜1.0%耐/νo1程度の濃度で存在させる
ことが好ましい。The culture of the above-mentioned transformed bacterium varies depending on the type of host bacterium, but in general, it can be carried out using commonly used synthetic or natural media. As a carbon source, various carbonized substances such as gluten □, glycerol, 7-lactose, sucrose, and molasses can be used. As a nitrogen source, tryptone, yeast extract,
Natural nitrogen sources such as corn steep liquor and casein hydrolyzate can be used. Many natural organic nitrogen sources can serve as carbon sources as well as nitrogen sources. In addition, the medium contains L-
) lipdoan and/or 5-methyltryptophan,
It is preferable that a tryptophan derivative such as 5-oxytryptophan be present at a concentration of usually 0.01% (4 t/vol) or more, preferably about 0.1% to 1.0% resistance/vo1.
培養は、振盪培養あるは通気攪拌深部培養などの好気的
条件下に行うことができる。培養温度は一般に20〜s
o’ct’あり、培地中の培地のp )−1は中性また
は微アルカリ性附近に維持することが望ましい、培養期
間は、通常1〜5日である。Cultivation can be carried out under aerobic conditions such as shaking culture or submerged culture with aeration. Culture temperature is generally 20~s
p)-1 of the medium in the culture medium is preferably maintained near neutral or slightly alkaline, and the culture period is usually 1 to 5 days.
上記のような培養方法によって得らhだ菌体又はその処
理物を用いてインドールとピルビン酸またはその塩とア
ンモニウムイオンとを反応せしめて1)られる、反応液
中に生成したL−トリプトファンの分離・調製は、イオ
ン交換ム(N、活性炭等による吸着、脱着処理等の公知
の方法に上り行うことがcきる。1) Separation of L-tryptophan produced in the reaction solution obtained by reacting indole, pyruvic acid or its salt, and ammonium ion using the bacterial cells obtained by the above-mentioned culture method or a treated product thereof. - Preparation can be carried out using known methods such as adsorption and desorption treatment using ion exchange membranes (N, activated carbon, etc.).
また、本発明のプラスミドで形質転換した宿主菌はL−
トリプトファンの発酵法による生産にも利用することが
できる。すなわち、本発明のプラスミド″C形質転換し
た宿主をインドールを含む培地′C培養すれば、培地中
にL−)リプ)7アンが生産蓄積し、これを採取するこ
とによりL−)−リプドアアンを製造することができる
。Furthermore, the host bacteria transformed with the plasmid of the present invention is L-
It can also be used to produce tryptophan by fermentation. That is, when a host transformed with the plasmid "C" of the present invention is cultured in a medium "C" containing indole, L-)lip)7an is produced and accumulated in the medium, and by collecting it, L-)-lipdooran can be obtained. can be manufactured.
犬に実施例により本発明のプラスミドの調製についてさ
らに具体的に説明する。The preparation of the plasmid of the present invention will be explained in more detail using Examples for dogs.
実施例1ニブラスミド MTP−1[7MTP−11立
x]−
A)x>z−ユhIヒニリ−(E 5ehcrichi
a co↓ゆL培地(トリプトン10g、酵母エキス
5g、グルコース1g、NaC15g、J’留水IN、
pH7,2)100(至)1を容1500曽1の三角7
ラスフに分注し、120°Cで15分間滅菌処理した。Example 1 Niblasmid MTP-1 [7MTP-11 x] - A)
a co↓YuL medium (10 g of tryptone, 5 g of yeast extract, 1 g of glucose, 15 g of NaC, J' distilled water IN,
pH7,2) 100 (to) 1 to 1500 so 1 triangle 7
The mixture was dispensed into Raphs and sterilized at 120°C for 15 minutes.
この培地にエシェリヒア・コリ(Espberichi
a col’i)K 12ATCC27325を植菌
し、37゛Cで15時間培養を行った後、この培1!液
2鐘1を探り、新たに上記培地100m1に接種し、再
度37°Cで4時開培養を行なった。This medium contains Escherichia coli (Espberichi).
After inoculating K 12ATCC27325 and culturing at 37°C for 15 hours, this culture 1! Solution 2 and Volume 1 were found, newly inoculated into 100 ml of the above medium, and cultured again at 37°C with opening at 4 o'clock.
培養終了後、この培1!液全量を遠心分離(8000×
8.15分間、4°C)して集菌し、菌体を50t*M
) リ ス援衝a(pH8,0)−10mM E
DTA・2Na溶液50+ell:懸濁した。次にリゾ
ナウムを最終濃度が2o+g/mlになるように添加し
、5分開靜置後、10%ドデシル硫酸ナトリウムa液を
6−1添加し、65°Cで30分間保温した。この溶菌
液に、5M NaC1溶液15m1を添加し、0°C
で1時間冷却し、全量を遠心分離(12000×g、6
0分間、4 ’C) L、上清画分を分取し、2倍量の
エタ/−ルを加え、混合後、遠心分離(5000Xg、
10分間、4°C)した、得られた沈澱物を10mM)
リス緩衝液(pH7,5)−1+sMEDT A・2N
a78液で溶解させ、7エ/−ル処理(除タンパク処理
)およびRNA分解酵素による処理をイテない、最終的
にDNA1.5mgを得た。After culturing, this culture 1! Centrifuge the entire liquid (8000x
8.15 minutes at 4°C) to collect bacteria, and collect 50t*M of bacterial cells.
) Squirrel supplement a (pH 8,0)-10mM E
DTA・2Na solution 50+ell: Suspended. Next, rhizonaum was added to the final concentration of 2o+g/ml, and after the mixture was allowed to stand for 5 minutes, 10% sodium dodecyl sulfate solution A was added at 6-1, and the mixture was kept at 65°C for 30 minutes. Add 15 ml of 5M NaCl solution to this lysate and heat at 0°C.
Cool for 1 hour and centrifuge the entire volume (12,000 x g, 6
0 minutes, 4'C) L, separate the supernatant fraction, add twice the amount of ethanol, mix, and centrifuge (5000Xg,
The resulting precipitate was diluted to 10mM) for 10 min at 4°C.
Squirrel buffer (pH 7,5)-1+sMEDT A・2N
The DNA was dissolved in A78 solution and subjected to 7 el/-el treatment (protein removal treatment) and treatment with RNA degrading enzyme to finally obtain 1.5 mg of DNA.
B) )リブト−7アナーゼをHる゛ uL前記(A
)で調製した染色体DNA25μgを、制限酵X)[1
ndll及びBamHI(各々50 units)を用
い30°C11時間反応、で切断し、染色体DNAのH
indl及びBa鴎HT分解物溶液を?A製した。B) ) Ribto-7 anase was purified (A
25 μg of chromosomal DNA prepared in ) was treated with restriction enzyme X) [1
The H
indl and Bagu HT decomposition product solution? Made by A.
この分)If、物ン容液1こプラスミドpBR3221
ggを制限酵2 f−(i nd II!及び13am
I4I(各1 unit)を用い30°C11時間反応
、で切断して得た分解物溶液をン五合し、50翔〜1ト
リス援衝液(pH7,6>、10mM)千オスレイトー
ル、1懐M ATP、10 m M !’ii g
Cl 2及びT4す〃−ゼ1uniしの各成分を添加し
く各成分の濃度は最終濃度である)、16℃で15時開
反応させ、結合させた。If) 1 volume of plasmid pBR3221
gg with restriction enzyme 2f-(ind II! and 13am
The decomposition product solution obtained by cleavage using I4I (1 unit each) at 30°C for 11 hours was mixed with 50 to 1 Tris-enriched solution (pH 7.6>, 10 mM), 1,000 osthreitol, and 1 ml. ATP, 10mM! 'ii g
Cl 2 and 1 ml of T4 sugar were added (the concentrations of each component were the final concentrations), and the mixture was allowed to react at 15:00 at 16° C. for binding.
この溶状を用い、常法[M−Mandcl、A)(ig
a; J 、 M of、 B iol、 、旦、15
9(1970)参照1に従って、エシエリヒア・コリ(
E 5cbcrichiaColi)K 12系株(ト
リプトアナーゼ欠損変異およびトリプトアナーゼ要求性
変異株)を形質転換し、選択培地(KzHPO478、
KH,Po。Using this solution, use the conventional method [M-Mandcl, A) (ig
a; J, Mof, Biol, , Dan, 15
9 (1970) ref. 1, Esierichia coli (
E5cbcrichia coli) K12 strain (tryptoanase-deficient mutant and tryptoanase auxotrophic mutant) was transformed, and selective medium (KzHPO478,
K.H., Po.
2g、(NH+)2sOn1g、MgSO4・7H20
0,1g、カザミノ酸、sFl、DL−5−メチル−ト
リプトファン 50B、グリセリン2g、寒天20g、
純水11)に塗抹した。この培地上の生「株をL培地に
アンピシリンを最終濃度で50μg/ +n l ”7
む培地に植菌し、37°Cで7時開培重した後、m体を
遠心分離(8000Xg、10分間、4℃)により巣め
た。この菌体を用いてYリブドア7ナーゼ活性を調べた
。2g, (NH+)2sOn1g, MgSO4・7H20
0.1g, casamino acid, sFl, DL-5-methyl-tryptophan 50B, glycerin 2g, agar 20g,
It was smeared on pure water 11). Transfer the live 'strain on this medium to L medium with ampicillin at a final concentration of 50 μg/+n l'7
After culturing and weighting at 37°C for 7 hours, the m bodies were incubated by centrifugation (8000×g, 10 minutes, 4°C). Using this bacterial cell, Y ribdoor 7nase activity was examined.
反応液(0,IMリン酸緩衝液p[(8,0,10慎M
) 17 7’ ) 7 7 :/ 、
0 、1 % ) ’J ) ン X−100
)1mlに7gm体50mgを加え、37°Cで30分
間反応させた。生成するインドールをp−ノメチルベン
:!:アルデヒドを用いて呈色させたところ、赤色に呈
色した株が得られた。この株より、アルカリ−3DS
法[T、Maniatis+E、F、Fr1tsch+
J、Sambrook;“Mo1ecular
eloieng”(1982)p90〜91参照1に
よりプラスミドを抽出し、プラスミドをBawHI及び
Hind[[で切断し分子量を7ガロースデルを用いて
調べたところ、pBR322のHindllI及びBa
wHI?fK位に約3.2kbのDNAの挿入がみられ
た。Reaction solution (0,IM phosphate buffer p[(8,0,10cm
) 17 7' ) 7 7 :/ ,
0, 1%) 'J) N X-100
) 50 mg of 7gm was added to 1 ml and reacted at 37°C for 30 minutes. The indole produced is p-nomethylben:! : When colored using aldehyde, a red colored strain was obtained. From this strain, Alkali-3DS
method [T, Maniatis+E, F, Fr1tsch+
J, Sambrook;
eloieng" (1982) p90-91 reference 1, the plasmid was cut with BawHI and Hind[[, and the molecular weight was examined using a 7 galose del.
wHI? Approximately 3.2 kb of DNA was inserted at position fK.
さらに、このプラスミド溶液を用いて、上記宿主に再形
質転換したところ、約10 ’cells/μgDNA
の頻度で選択培地に生育する株が現れた。Furthermore, when the above host was retransformed using this plasmid solution, approximately 10' cells/μg DNA
Strains that grew on the selective medium appeared at a frequency of .
C) Fプラスミド白米m1ni−F−断りγ!λ土
し堡−り培地にエシエリヒア・コリ(E 5chcri
chiaColi)Kl 2 YK2004(FER
M−P−7838)を植菌し、アルカリ−6DS法によ
りプラスミドpMTY−2を抽出した。このプラスミド
pMTY−22μgと、前記プラスミドpBR322−
tnaA1/jHを制限酵素E eoRT 5 un
itsを用いて37°Cで1時間反応させるこにより切
断し、65°Cで10分間保温することにより、Eco
RIを失活させrこ後、該失活溶液中の成分が最終濃度
として各々50協Mトリス緩衝液pH7,6、lon+
MMgC+□、10uMノチオスレイトール、1mMA
TP及びT 41J 、f−ゼlun己になるように各
成分を強化し、16゛Cで15時間保温しtこ。この溶
液を用いてエシェリヒアやコリ(Eschcricl目
acoli)K 12系株(トリプトアナーゼ欠損変異
及びトリプトファン要求性変異株)を常法に従って形質
転換させ、上記選択培地に塗床し、37℃で2日間培養
した。生育してきた株につき、アルカリ−3DS法によ
りプラスミドを抽出し、制限酵素EeoR1(5uni
ts)およゾH1ndlII (5units)を用い
てプラスミドを切断し、アガロースデル電気泳動を用い
て分子量を測定したところ、プラスミドpMTY−2に
含まれているuini−F断片(9,2kb)がEco
RIe位に組み込よrLだプラスミドが5つ(%)得ら
れた。さらに、これら5つのプラスミドのHindll
切断パターンを調べたところ、1ini−F断片が異な
る配位で結合したプラスミドが1つ存在することを確認
した。これらのプラスミドをpMTP−1及びpMTP
−IRと命名し、それらの制限酵素切断地図は第1図及
び第2図に示すとおりであった。C) F plasmid white rice m1ni-F-refusal γ! Escherichia coli (E 5 chcri
chiaColi) Kl 2 YK2004 (FER
M-P-7838) was inoculated, and plasmid pMTY-2 was extracted by the alkali-6DS method. This plasmid pMTY-22 μg and the plasmid pBR322-
tnaA1/jH with restriction enzyme EeoRT 5 un
Eco
After inactivating the RI, the components in the inactivation solution were adjusted to a final concentration of 50 μM Tris buffer pH 7.6, lon+, respectively.
MMgC+□, 10uM nothiothreitol, 1mMA
TP, T41J, and each component were strengthened to form f-gel and kept warm at 16°C for 15 hours. Using this solution, Escherichia and coli K12 strains (tryptoanase-deficient mutants and tryptophan auxotrophic mutants) were transformed according to a conventional method, plated on the above selective medium, and cultured at 37°C for 2 days. did. Plasmids were extracted from the grown strains by the alkaline-3DS method, and restriction enzyme EeoR1 (5 uni
The plasmid was cut using plasmid pMTY-2 and EcoH1ndlII (5 units), and the molecular weight was measured using agarose del electrophoresis.
By integrating into the RIe position, 5 (%) rL plasmids were obtained. Furthermore, Hindll of these five plasmids
When the cleavage pattern was examined, it was confirmed that there was one plasmid in which the 1ini-F fragment was linked in a different coordination. These plasmids were transformed into pMTP-1 and pMTP
-IR, and their restriction enzyme cleavage maps are as shown in FIGS. 1 and 2.
L培地(トリプトン10g、酵母エキス58、NaC1
5g、グルツース1g、蒸留水11p87.2)100
mlを容量500II+lの三角フラスコに分注し、1
20°Cで15分間滅菌処理した。この培地にエシエリ
ヒア・コリ(Esehcrichia eoli)K
12ATCC27325株を公知の方法[実験農芸化
学(下)fjS3版P226〜230(31j京大学農
学部S芸化学教室編、朝倉書店、昭和53年5月25日
発行)参照1で処理した変異株()リプドアアン要求、
アデニン要求)リブト7アナーゼ欠失)を稙mし、37
°Cで15時間培養を行なった後、この培養−a2ml
を探り、新たに上記培地100m1に接種し、再度37
℃で2時間培養を行なった。培養終了後、この培養物の
30m1を無菌的に遠心分離(8000Xg、5分間
4°C)して集菌した。L medium (tryptone 10g, yeast extract 58, NaCl
5g, Glutoose 1g, distilled water 11p87.2) 100
Dispense ml into an Erlenmeyer flask with a capacity of 500 II + l, and add 1
Sterilization was performed at 20°C for 15 minutes. In this medium, Esehcrichia coli (Esehcrichia eoli) K.
12ATCC27325 strain was treated with a known method [Jikken Agricultural Chemistry (Part 2) fjS3 edition P226-230 (31j Kyoto University Faculty of Agriculture S Art Chemistry Department, edited by Asakura Shoten, May 25, 1976) Reference 1 Mutant strain () Reply door unrequested,
37
After 15 hours of incubation at °C, 2 ml of this culture
100ml of the above medium was newly inoculated, and 37ml was added again.
Culture was performed at ℃ for 2 hours. After culturing, 30ml of this culture was aseptically centrifuged (8000Xg, 5 minutes).
4°C) to collect bacteria.
滅菌処理を行なった1 00mM MgCl2溶液3
0m1に懸濁後、遠心分離(8000xg5分開分開’
C)を行ない。あらかじめ0”Cに冷却しておいた滅菌
処理済の100mM CaCl210a+Iに再懸濁
し、この懸濁液を水中にて、1時開冷却した。Sterilized 100mM MgCl2 solution 3
After suspending at 0ml, centrifugation (8000xg for 5 minutes)
Do C). It was resuspended in sterilized 100mM CaCl210a+I that had been previously cooled to 0''C, and this suspension was cooled in water for 1 hour.
冷却終了後、この懸濁i([100μmにプラスミドp
MTP−10,5μg又はpMTP−IRo。After cooling, this suspension i ([plasmid p
MTP-10.5 μg or pMTP-IRo.
5μgを添加し、水中にて30分間冷却した。次に42
°Cにて2分間加温し、選択培地(K2HPOイアg、
KH2PO42g、(NH4)2SOイ 1g、Mg6
0.7HzOO,Ig、 カザミノ酸 58、DL−
メチルトリプトファン50mg、塩酸アデニン50B、
グリセリン2g1アンビンリン201I+g、寒天20
g、純水12)に塗床し、37゛Cにて24時間培養し
、生ゴした菌株を得た。プラスミドpM TP −1で
形質転換された株をYK3002と命名し、プラスミド
pMTP−1Rで形質転換された株をYK3003と命
名した。5 μg was added and cooled in water for 30 minutes. Next 42
Incubate at °C for 2 minutes and use selective medium (K2HPOiag,
KH2PO42g, (NH4)2SOi 1g, Mg6
0.7HzOO, Ig, Casamino Acid 58, DL-
Methyltryptophan 50mg, adenine hydrochloride 50B,
Glycerin 2g1 Anbinlin 201I+g, Agar 20
g, pure water 12) was plated and cultured at 37°C for 24 hours to obtain a raw bacterial strain. The strain transformed with plasmid pMTP-1 was named YK3002, and the strain transformed with plasmid pMTP-1R was named YK3003.
出」y−柩スm咀り1追Z15ぼりt戊J−pMTP−
1105
pM105p F< 1 0’対
照区 O
このプラスミドpMTP−1を保持する形質転換株エシ
エリヒア・コリに12 YK3002は、茨城県筑波
部谷田部町東1丁目1番3号の工業技術院微生物工業技
術研究所に、昭和61年7月10日付℃受託番号:徽工
研寄第8844号(F E RM P−8844)と
して、そしてプラスミドpMTP−IRを保持する形質
転換株エシェリヒア・フ17 K 12 Y K 3
003は、同様に昭和61年7月10日付で受託番号:
微工研寄ptfJ8845号(FERM P−884
5)として寄託されている。Out” y-coffin m Tsui 1 Oi Z15 t 戊J-pMTP-
1105 pM105p F< 1 0' Control group O 12 YK3002 was transferred to the transformed strain Escherichia coli carrying this plasmid pMTP-1. on July 10, 1985, and the transformed strain Escherichia F17 K12 YK3 carrying the plasmid pMTP-IR was designated
003 is also the accession number dated July 10, 1986:
Microtechnology Research Institute PTFJ8845 (FERM P-884
It has been deposited as 5).
実施例3:U−転」灸生立交疋1
前記の選択培地100m1を500m1容三角フラスコ
に分注し、120℃で15分間滅菌処理したものに、実
施例2で得た形質転換株をそれぞれ植菌し、37°Cに
て24時間振盪培養を行なった後、同様にして調製した
L培地1001を500m1容三角プラスフに分注し、
120 ’Cで15分間滅菌したものに101当050
cellsの左1合になるように稙継し、同じく37°
Cにて24時間振盪培養を行なった6次に遠心分離数を
用いて集菌し、菌体を洗浄後、アンピシリンを50μ8
/請1の割合で添加したし培地および無添加のL培地と
して調製した平板培地に一定量塗抹し、37゛Cにて1
日培養後生をコロニーをカウントする。Example 3: U-transformation moxibustion growth 1 100 ml of the above selective medium was dispensed into a 500 ml Erlenmeyer flask, sterilized at 120°C for 15 minutes, and the transformed strain obtained in Example 2 was added to each of the flasks. After inoculating and culturing with shaking at 37°C for 24 hours, L medium 1001 prepared in the same manner was dispensed into a 500ml triangular plastic tube.
050 per 101 sterilized at 120'C for 15 minutes
Connect the base so that it is 1st to the left of cells, and also 37°
After culturing with shaking for 24 hours at
A certain amount was spread on a plate culture medium prepared as L medium and L medium without additives at a ratio of 1/1 and 1 at 37°C.
Count the viable colonies after a day of culture.
この結果、どちらの形質転換株らアンピリジン添加およ
び無添加培地に生をしたコロニーは同数であること、さ
らにL培地生■コロニーは全て実施例1で用いた選択培
地に生をすること、すなわち該プラスミドの高度の安定
性を確認した。As a result, it was found that the number of colonies that grew on the ampyridine-added and non-ampyridine medium was the same for both transformed strains, and that all L-medium-grown colonies grew on the selective medium used in Example 1. The high degree of stability of the plasmid was confirmed.
実施例3ニトリブト7アナーイ遁1−O」見り培地10
0曽1を500+al容三角フラスコに分注し、120
°Cで15分間滅菌処理したらのに、実施例1で得tこ
形質転換株を植菌し、37゛Cにて1日振盪培養後、同
様にして調製したトリプトファンを200pFi/ml
の濃度で含有するし培地100儂1に0 、2 ml接
種し、同じく37°Cにて8時間振盪培養した。該培1
!液を遠心分離することにより菌体をi菌し、100+
M)リス緩i液(pH8,0)50IllIにて洗浄し
、再び遠心分離を行い集画後、湿漬体を20011g採
取し、1輸Iの100−Mトリス緩衝[(pH8、O)
に懸濁し超音波処理を行なった。処理後の菌体破砕物を
適当に100mN・1トリス緩衝液(p!48.0)で
希釈して、1恒1中に1 0 0 μmole)
リ スff1itia(pH8,0) 、 100 μ
mole K Cl、10μmole L−トリプ
トファン、0.03μmoleピリドキサールー5−リ
ン酸を含む反応液に加えて37°C15分間反応させた
後、常法[0,H,S+5iLh and C,Y
anofasky:Methodsin E nz
ymology”、 A cademic+ N
ew Y ork(1962)、vol 5、p
794〜8061に従い生成するインドールを定量した
。Example 3 Nitribut 7 Anai Ton 1-O'Mimi Medium 10
Dispense 0 so 1 into a 500+ al Erlenmeyer flask, 120
After sterilization at 15°C for 15 minutes, the transformed strain obtained in Example 1 was inoculated, and after cultured with shaking at 37°C for 1 day, tryptophan prepared in the same manner was added to 200 pFi/ml.
0.2 ml was inoculated into 100 ml of a culture medium containing a concentration of 0.2 ml, and cultured with shaking at 37°C for 8 hours. Said culture 1
! By centrifuging the liquid, the bacterial cells were isolated to 100+
M) After washing with 50 IllI of Squirrel slow solution (pH 8, 0), centrifuging again and collecting, 20,011 g of the wet body was collected, and 1 infusion of 100-M Tris buffer [(pH 8, O)
was suspended in water and subjected to ultrasonication. After treatment, the crushed bacterial cells were diluted appropriately with 100 mN/1 Tris buffer (p! 48.0), and 100 μmole in 1 solution was added.
Squirrel ff1itia (pH 8,0), 100 μ
It was added to a reaction solution containing mole K Cl, 10 μmole L-tryptophan, and 0.03 μmole pyridoxal-5-phosphate and reacted at 37°C for 15 minutes, followed by a conventional method [0,H,S+5iLh and C,Y
anofasky:Methods in E nz
ymology”, A academic+N
ew York (1962), vol. 5, p.
794-8061, the indole produced was quantified.
その結果、本発明のプラスミドpMTP−1又はpMT
P−IRを保持する大腸菌(FERM P−8844
及びFERM P−8845)を用いた場合、活性は
いずれも約150 units(1unit= 0 、
1μΦo1e生成したインドールffi/−gタンパク
i/20分)であった、また、対照として、m1ni−
Fを含まないプラスミドpB R322−LnaAを保
持する大腸直を用いて、上記方法で活性を調べたところ
、約70 unitsの活性値を示した。As a result, plasmid pMTP-1 or pMT of the present invention
E. coli harboring P-IR (FERM P-8844
and FERM P-8845), the activity was about 150 units (1 unit = 0,
As a control, m1ni-
When the activity was examined by the above method using a rectal colon carrying the F-free plasmid pB R322-LnaA, it showed an activity value of about 70 units.
実施例4:L−)リブドアアンの1力−下記組成のし培
地50m1を5001111容三角フラスコに分注し、
120°Cで15分間滅菌処理したものに上記実施例2
で得た形質転換株エシエリヒア・コリに−12(FPR
M P−8844及VF゛PRM P−8845)
を植菌し、37゛Cにて1日振盪培!!後、同様にして
調製したL−)リブドアアンを200pg/mlの濃度
で含有するL培地100a+lに2ω1接触し、同じく
37°Cにて8時間振盪培養した。Example 4: L-) Ribdoor Anne's 1 force - Dispense 50 ml of a medium having the following composition into a 5001111 volume Erlenmeyer flask,
The above Example 2 was sterilized at 120°C for 15 minutes.
-12 (FPR
MP-8844 and VF゛PRM P-8845)
Inoculate and culture with shaking at 37°C for 1 day! ! Thereafter, the cells were brought into 2ω1 contact with 100a+l of L medium containing L-) ribdoan prepared in the same manner at a concentration of 200 pg/ml, and cultured with shaking at 37°C for 8 hours.
し慶邦の組(
トリプトン 10g
酵母エキス 5g
NaCl 5g
グルコース 1g
蒸留水 12
pH7,2
遠心分離機を用いて菌体を回収し、これをインドール1
.5g、ピルビン酸ナトリウム1.5g、酢酸アンモニ
ウム1.5g、ピリドキサールリン酸0゜5B及び「ト
リトンX−100j5gを含む100mMトリス緩i液
(pH8、5)50mlに懸濁し、振盪しながら37℃
で5時間反応を行なった。反応終了後、反応物を水で1
0倍に希釈したのち、遠心分離により得た上澄液につい
て高速液体クロマトグラフィーで生成したL−)リプド
アアンの分析を行なったところ、いずれの形質転換株を
用いた場合にも、2.1B/111のL−)リプドア7
ンの生成が認められた。Shi Yoshikuni's group (Tryptone 10g Yeast extract 5g NaCl 5g Glucose 1g Distilled water 12 pH 7.2 Collect the bacterial cells using a centrifuge and indole 1
.. 5 g of sodium pyruvate, 1.5 g of ammonium acetate, 0.5 g of pyridoxal phosphate, and 5 g of Triton
The reaction was carried out for 5 hours. After the reaction is complete, add 1 portion of the reactant with water.
After diluting to 0 times, the supernatant obtained by centrifugation was analyzed for L-) lipoan produced by high performance liquid chromatography, and it was found that 2.1B/ 111 L-) Lipdore 7
Formation of ions was observed.
反応終了f!50m1の10倍希釈液500鰺1をアン
モニア型強酸性イオン交換樹脂(ダイヤイオン5K−I
B、三菱化!!、製)のカラムを通してL−)リブドア
アンを吸Nさせたのち、アルカリ溶液で溶出後、濃縮し
L−)リブドアアンの粗結晶を析出させた。これをア七
トンで洗浄し乾燥してL−トリブトファンの結晶を0.
7gを得た。Reaction completed f! Add 50 ml of 10 times diluted solution 500 mackerel to an ammonia-type strongly acidic ion exchange resin (Diaion 5K-I).
B.Mitsubishi! ! After absorbing N through a column manufactured by L-) Ribbed Anne, L-) Ribbed Anne was eluted with an alkaline solution and concentrated to precipitate crude crystals of L-) Ribbed Anne. This was washed with amethane and dried to obtain 0.0% L-tributophane crystals.
7g was obtained.
なお、対照のためmi旧−F断片を含まない、プラスミ
ドpB R322−tnaAを含有する形質転換株を用
いて同様の毘(乍でL−)リブドアアンを生成させたと
ころ、L−)リブドアアンの結晶が0゜3gしか得られ
なかった。As a control, a similar bi(L-) ribdoane was produced using a transformed strain containing the plasmid pB R322-tnaA, which does not contain the mi old-F fragment. Only 0.3g of was obtained.
fpJ1図及び第2図はそれぞれプラスミドpMTP−
1及びpMTP−IRの制限酵素切断地図である。fpJ1 diagram and Figure 2 are respectively plasmid pMTP-
1 and pMTP-IR restriction enzyme cleavage maps.
Claims (1)
ロモーター及びこのプロモーターを制御する調節遺伝子
並びにトリプトアナーゼ構造遺伝子を含むDNA断片と
、 (b)ColEl系プラスミドの自律増殖能を司るDN
A断片と、 (c)Fプラスミド由来の増殖制御分配系を司る遺伝子
を含むDNA断片 とから成ることを特徴とする新規なプラスミド。 2、ColEl系プラスミドの自律増殖能を司るDNA
断片(b)がpBR322由来のものである特許請求の
範囲第1項記載のプラスミド。 3、Fプラスミドの増殖制御分配系を司る遺伝子(c)
がminiF断片である特許請求の範囲第1項又は第2
項記載のプラスミド。 4、トリプトアナーゼオペロンの少なくともプロモータ
ー及びこのプロモーターを制御する調節遺伝子並びにト
リプトアナーゼ構造遺伝子を含むDNA断片(a)が、
大脹菌K12系株の染色体DNAを制限酵素BamH
I 及びHindIIIで切り出すことにより得られる分子
量が約3.2KbのDNA断片である特許請求の範囲第
1〜3項のいずれかに記載のプラスミド。 5、プラスミドpMTP−1又はpMTP−1Rである
特許請求の範囲第1〜4項のいずれかに記載のプラスミ
ド。 6、分子量が約10.7メガダルトンであり、制限酵素
BamH I 、HindIII及びEcoR I に対する切
断部位がそれぞれ3ヶ所、2ヶ所及び2ヶ所であり、且
つEcoR I による切断断片の分子量が約6.0メガ
ダルトン及び約4.7メガダルトンであり、BamH
I による切断断片が約6.4メガダルトン、約2.7メ
ガダルトン及び約1.6メガダルトンであり、そしてH
indIIIによる切断断片が約5.5メガダルトン及び
約5.2メガダルトンであることを特徴とするプラスミ
ドpMTP−1である特許請求の範囲第5項記載のプラ
スミド。 7、分子量が約10.7メガダルトンであり、制限酵素
BamH I 、HindIII及びEcoR I に対する切
断部位がそれぞれ3ヶ所、2ヶ所及び2ヶ所であり、且
つEcoRIによる切断断片の分子量が約6.0メガダ
ルトン及び約4.7メガダルトンであり、BamH I
による切断断片が約7.0メガダルトン、約2.1メガ
ダルトン及び約1.6メガダルトンであり、そしてHi
ndIIIによる切断断片が約10.2メガダルトン及び
約0.5メガダルトンであることを特徴とするプラスミ
ドpMTP−1Rである特許請求の範囲第5項記載のプ
ラスミド。 8、プラスミドpMTP−1又はpMTP−1Rで形質
転換されたエシエリヒア・コリK12系微生物。 9、トリプトフアナーゼオペロン中の少なくともプロモ
ーター及びこのプロモーターを制御する調節遺伝子並び
にトリプトフアナーゼ構造遺伝子を含むDNA断片とC
olE1系プラスミドの自律増殖能を司るDNA断片と
Fプラスミド由来の増殖制御分配系を司る遺伝子を含む
DNA断片とから成るプラスミドで形質転換されたエシ
エリヒア・コリの培養物又はその処理物の存在下に、イ
ンドールとピルビン酸又はその塩とアンモニア又はアン
モニウムイオンとを反応させることを特徴とするL−ト
リプトフアンの製造法。[Scope of Claims] 1. (a) A DNA fragment containing at least a promoter in the tryptoanase operon, a regulatory gene that controls this promoter, and a tryptoanase structural gene, and (b) a DNA that controls the autonomous replication ability of ColEl-based plasmids.
A novel plasmid characterized in that it consists of an A fragment and (c) a DNA fragment containing a gene controlling a growth control distribution system derived from the F plasmid. 2. DNA governing autonomous replication ability of ColEl-based plasmids
The plasmid according to claim 1, wherein fragment (b) is derived from pBR322. 3. Gene controlling the F plasmid growth control distribution system (c)
Claim 1 or 2, wherein is a miniF fragment.
Plasmids described in section. 4. A DNA fragment (a) containing at least a promoter of the tryptoanase operon, a regulatory gene that controls this promoter, and a tryptoanase structural gene,
The chromosomal DNA of B. enterica K12 strain was digested with the restriction enzyme BamH.
The plasmid according to any one of claims 1 to 3, which is a DNA fragment having a molecular weight of about 3.2 Kb obtained by excision with HindIII and HindIII. 5. The plasmid according to any one of claims 1 to 4, which is plasmid pMTP-1 or pMTP-1R. 6. The molecular weight is about 10.7 megadaltons, the cleavage sites for the restriction enzymes BamHI, HindIII, and EcoRI are 3, 2, and 2, respectively, and the molecular weight of the fragment cleaved by EcoRI is about 6. 0 megadaltons and about 4.7 megadaltons, and BamH
The cleavage fragments by I are about 6.4 megadaltons, about 2.7 megadaltons and about 1.6 megadaltons, and H
The plasmid according to claim 5, which is a plasmid pMTP-1, characterized in that the indIII cleavage fragments are about 5.5 megadaltons and about 5.2 megadaltons. 7. The molecular weight is approximately 10.7 megadaltons, the cleavage sites for the restriction enzymes BamHI, HindIII, and EcoRI are 3, 2, and 2, respectively, and the molecular weight of the fragment cleaved by EcoRI is approximately 6.0. megadalton and approximately 4.7 megadalton, BamH I
The cleavage fragments by Hi
6. The plasmid according to claim 5, which is a plasmid pMTP-1R, characterized in that the ndIII cleavage fragments are approximately 10.2 megadaltons and approximately 0.5 megadaltons. 8. Escherichia coli K12 microorganism transformed with plasmid pMTP-1 or pMTP-1R. 9. A DNA fragment containing at least a promoter in the tryptophanase operon, a regulatory gene that controls this promoter, and a tryptophanase structural gene;
In the presence of a culture of Escherichia coli transformed with a plasmid consisting of a DNA fragment controlling the autonomous propagation ability of the olE1-based plasmid and a DNA fragment containing a gene controlling the growth control distribution system derived from the F plasmid, or a processed product thereof. A method for producing L-tryptophan, which comprises reacting indole, pyruvic acid or a salt thereof, and ammonia or ammonium ion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61169859A JPS6328393A (en) | 1986-07-21 | 1986-07-21 | Novel plasmid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61169859A JPS6328393A (en) | 1986-07-21 | 1986-07-21 | Novel plasmid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6328393A true JPS6328393A (en) | 1988-02-06 |
Family
ID=15894262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61169859A Pending JPS6328393A (en) | 1986-07-21 | 1986-07-21 | Novel plasmid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6328393A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02255082A (en) * | 1989-03-28 | 1990-10-15 | Toray Ind Inc | Transformant having tryptophanase productivity and production of l-tryptophan |
US5279951A (en) * | 1989-05-08 | 1994-01-18 | Research Association For Utilization Of Light Oil | Cultivation of transformed microorganisms |
US10704808B2 (en) | 2015-08-26 | 2020-07-07 | Phc Holdings Corporation | Ultra-low temperature freezer |
-
1986
- 1986-07-21 JP JP61169859A patent/JPS6328393A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02255082A (en) * | 1989-03-28 | 1990-10-15 | Toray Ind Inc | Transformant having tryptophanase productivity and production of l-tryptophan |
US5279951A (en) * | 1989-05-08 | 1994-01-18 | Research Association For Utilization Of Light Oil | Cultivation of transformed microorganisms |
US10704808B2 (en) | 2015-08-26 | 2020-07-07 | Phc Holdings Corporation | Ultra-low temperature freezer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU196843B (en) | Process for producing l-lysine | |
JPS6279788A (en) | Production of amino acid | |
JPS63233798A (en) | Production of 5'-guanylic acid | |
JPS6328393A (en) | Novel plasmid | |
US4692409A (en) | Method for producing L-aspartic acid | |
JPH0142672B2 (en) | ||
US5279951A (en) | Cultivation of transformed microorganisms | |
JPH08168383A (en) | Production of hucleic acid-related substance | |
EP0281104B1 (en) | Novel plasmids | |
JPS6030693A (en) | Production of l-isoleucine | |
JPS61239896A (en) | Production of l-tryptophan | |
KR0185577B1 (en) | Preparation process of gene amplification vector and 5'-guanylic acid | |
KR970005914B1 (en) | Process for gmp by recombinant microorganism | |
JPH074257B2 (en) | Novel plasmid | |
JPS61247393A (en) | Production of l-tryptophan | |
JPH055479B2 (en) | ||
KR920008383B1 (en) | Method for producing l-lysine | |
JPH0468909B2 (en) | ||
JPH0595788A (en) | Recombinant plasmid and microorganism containing the same | |
JPH055480B2 (en) | ||
JPS61170391A (en) | Novel plasmid | |
JPH01265887A (en) | Plasmid | |
JPS61247394A (en) | Production of l-tryptophan | |
JPH04108388A (en) | New recombinant plasmid | |
JPH02276576A (en) | Production of tryptophanase |